- Home
- LSBK vs WGSWW Comparison
LSBK vs WGSWW Comparison
Compare LSBK & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- WGSWW
- Stock Information
- Founded
- LSBK 1891
- WGSWW 2017
- Country
- LSBK United States
- WGSWW United States
- Employees
- LSBK N/A
- WGSWW 1000
- Industry
- LSBK Savings Institutions
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- LSBK Finance
- WGSWW Technology
- Exchange
- LSBK Nasdaq
- WGSWW Nasdaq
- Market Cap
- LSBK N/A
- WGSWW N/A
- IPO Year
- LSBK 2006
- WGSWW N/A
- Fundamental
- Price
- LSBK $14.81
- WGSWW $0.05
- Analyst Decision
- LSBK
- WGSWW
- Analyst Count
- LSBK 0
- WGSWW 0
- Target Price
- LSBK N/A
- WGSWW N/A
- AVG Volume (30 Days)
- LSBK 4.5K
- WGSWW 36.6K
- Earning Date
- LSBK 04-29-2025
- WGSWW 02-18-2025
- Dividend Yield
- LSBK 4.80%
- WGSWW N/A
- EPS Growth
- LSBK 28.79
- WGSWW N/A
- EPS
- LSBK 0.90
- WGSWW N/A
- Revenue
- LSBK $25,795,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- LSBK N/A
- WGSWW N/A
- Revenue Next Year
- LSBK N/A
- WGSWW N/A
- P/E Ratio
- LSBK $16.41
- WGSWW N/A
- Revenue Growth
- LSBK N/A
- WGSWW 50.79
- 52 Week Low
- LSBK $11.42
- WGSWW $0.17
- 52 Week High
- LSBK $16.95
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- LSBK 48.63
- WGSWW N/A
- Support Level
- LSBK $14.53
- WGSWW N/A
- Resistance Level
- LSBK $15.22
- WGSWW N/A
- Average True Range (ATR)
- LSBK 0.23
- WGSWW 0.00
- MACD
- LSBK 0.05
- WGSWW 0.00
- Stochastic Oscillator
- LSBK 43.22
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.